Abstract Library
Members may log into MY ENETS to visit the abstract library from previous ENETS conferences.
Participants of the ENETS Conference in 2024 can now access the abstract booklet, e-posters and videos, slide decks of talks, the poster carousel, and more via My ENETS.
ENETS Abstract Search
Introduction: In a recent phase III study, Sunitinib has shown significant improvement of progression-free survival in patients with pancreatic NET.
Conference: 11th Annual ENETSConcerence (2014)
Presenting Author:
Authors: Marconcini R, Galli L, Antonuzzo A, Bracco E, Farnesi A,
Keywords: sunitinib, everolimus,
Introduction: PROMID and CLARINET trials demonstrate an improvement in PFS of SSA v. placebo in WDNET.
Conference: 11th Annual ENETSConcerence (2014)
Presenting Author:
Authors: Marconcini R, Galli L, Antonuzzo A, Bracco E, Farnesi A,
Keywords: octreotide, lanreotide,
Introduction: Results from phase II and non-randomized trials with metronomic 5-FU in combination with SSA in well-differentiated (WD) NET are limited, and considered investigational.
Conference: 11th Annual ENETSConcerence (2014)
Presenting Author:
Authors: Marconcini R, Galli L, Antonuzzo A, Bracco E, Farnesi A,
Keywords: capecitabine,
Introduction: Contrast-enhanced ultrasonography (CEUS) allows characterization of the micro-vascularization of tumor lesions. Liver metastases (LM) from neuroendocrine tumors (NET) show a typical pattern on CEUS, consistent with a rapid, intense and homogeneous enhancement (hypervascular pattern) in the arterial phase.
Conference: 9th Annual ENETSConcerence (2012)
Presenting Author:
Authors: Ramundo V, Faggiano A, De Stefano G, Marciello F, Marotta V,
Keywords: neuroendocrine tumor, liver metastases, CEUS, prognostic factors, tumor detection,